Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
69.98
-0.03 (-0.04%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.30 billion as of September 26, 2025. Its market cap has increased by 54.15% in one year.
Market Cap
2.30B
Enterprise Value
2.15B
1-Year Change
54.15%
Ranking
Category
Stock Price
$69.98
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.30B, an increase of 1,489.30%. That is a compound annual growth rate of 124.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.30B | 17.92% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |